NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan

  • Written by ACN Newswire

image

TOKYO, Jan 23, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg, 5mg, and 10mg tablets, lemborexant) for treatment of insomnia.

DAYVIGO is a dual orexin receptor antagonist that inhibits orexin...

Read more: Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan